Frontlight ResearchEarly access
Trial site
Nanjing Gulou Hospital
- 6running trials
- 1closed trial
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- ANCA-associated vasculitis1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Gastric and oesophageal cancer1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Obesity1 trial
- Phase
- Phase 12 trials
- Phase 1/21 trial
- Phase 21 trial
- Phase 31 trial
- Status
- Active, not recruiting3 trials
- Not yet recruiting2 trials
- Completed1 trial
- Recruiting1 trial
- Lead sponsor
- Hoffmann-La Roche2 trials
- Dizal Pharmaceuticals1 trial
- Hangzhou Endonom Medtech Co., Ltd.1 trial
- Peking University1 trial
- Staidson (Beijing) Biopharmaceuticals Co., Ltd1 trial
- and 1 more
Running trials
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects
Not yet recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- ANCA-associated vasculitis1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Lung cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026